Investigating how a specific protein affects kidney damage from obesity

Role of Atp6ap2 in renal proximal tubule lipotoxicity

NIH-funded research University of Virginia · NIH-11012906

This study is looking at how a protein called ATP6AP2 affects kidney cells and their damage from obesity, hoping to find new ways to help people with kidney problems related to being overweight.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUniversity of Virginia NIH-funded
Lab location1 site (Charlottesville, United States)
Project IDNIH-11012906 on NIH RePORTER

What this research studies

This research focuses on understanding the role of a protein called ATP6AP2 in kidney cells, particularly how it contributes to kidney damage caused by obesity. The study examines how toxic lipids accumulate in kidney cells and how this process is influenced by obesity-related factors. By using animal models, the research aims to uncover the mechanisms behind these changes and identify potential new treatment strategies for obesity-related kidney disease.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals suffering from obesity-related chronic kidney disease.

Not a fit: Patients with kidney disease not related to obesity may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that better protect the kidneys from damage caused by obesity.

How similar studies have performed: Other research has shown promising results in understanding kidney damage mechanisms related to obesity, but this specific approach is relatively novel.

Where this research is happening

Charlottesville, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.